Advances in the treatment of lower-extremity ischemia-reperfusion injury
Frontiers in Pharmacology · 23.05.2025 · 16
DOI: 10.3389/fphar.2025.1576091 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 23.05.2025. Verfasst von Jin Peng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology and Vascular Surgery, The First Affiliated Hospital, Hainan Medical University, Haikou, China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lower-limb ischemia–reperfusion injury (LL-IRI) is a frequent and serious complication following reperfusion therapy for lower-limb arterial occlusion. It can be caused by trauma, arterial stenosis, thrombotic occlusion, and atherosclerosis. As a prevalent peripheral vascular disease, LL-IRI results in local tissue damage and triggers systemic inflammatory responses that can lead to multiple-organ dysfunction syndrome, as well as multiorgan failure and death in severe cases. Despite its clinical significance, the mechanisms underlying IRI remain poorly understood, and no specific targeted drugs or effective emergency interventions are currently available. Therefore, this review provides a comprehensive analysis of the domestic and international literature published over the past decade regarding the disease definition, pathogenesis, and therapeutic advances in LL-IRI. It summarizes current pharmacological and non-pharmacological interventions, including antioxidant stress management, anti-inflammatory approaches, and oxidative stress reduction strategies. This review aims to advance the exploration of LL-IRI pathogenesis and proposes novel therapeutic perspectives for innovative drug development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Interventional Radiology and Vascular Surgery, The First Affiliated Hospital, Hainan Medical University, Haikou, China.
- Department of Emergency, The First Affiliated Hospital, Hainan Medical University, Haikou, China.
- Key Laboratory of Emergency and Trauma Ministry of Education, College of Emergency and Trauma, Hainan Medical University, Haikou, China.
- Division of Vascular Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Ophthalmology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Zitieren
APA
Peng, J., Deng, T., Wang, X., Liang, J., Wu, J., Li, B., Lv, J., Wu, S., Zhong, S., Yao, C., & Jin, G. (2025). Advances in the treatment of lower-extremity ischemia-reperfusion injury. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1576091
Vancouver
Peng J, Deng T, Wang X, Liang J, Wu J, Li B, et al. Advances in the treatment of lower-extremity ischemia-reperfusion injury. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1576091
BibTeX
@article{Peng2025,
author = {Peng, Jin and Deng, Tang and Wang, Xunkai and Liang, Jinxi and Wu, Jiangpeng and Li, Binglong and Lv, Jun and Wu, Shenmei and Zhong, Shijie and Yao, Chen and Jin, Guiyun},
title = {Advances in the treatment of lower-extremity ischemia-reperfusion injury},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1576091}
}
EUVIMED